轻微的介血管增殖性IgA瘤病变,有或没有最小的疾病变化
Shulei Wang1,2, Bo Huang1,2, Peiheng Wang1,2
1Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, Henan, People's Republic of China.
Clinical and experimental medicine
|October 5, 2023
概括
轻度间增殖性IgA脏病与最小变化疾病 (MCD-IgAN) 的预后比非MCD-IgAN更好. 性综合征 (NS) 可以帮助区分这些疾病,有助于治疗和预测IgA病患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病理学 病理学 病理学
- 免疫学 免疫学 免疫学
背景情况:
- 轻度的间增殖性IgA脏病 (M-IgAN) 在光显微镜上呈现出相似的情况,无论是否存在最小变化疾病 (MCD-IgAN).
- 在MCD-IgAN和非MCD-IgAN之间的临床和预后差异还没有得到很好的定义.
研究的目的:
- 与非MCD-IgAN相比,研究轻度间增殖性IgA缩症与最小变化疾病 (MCD-IgAN) 的临床病理特征和预后.
- 评估性综合征 (NS) 作为区分MCD-IgAN与非MCD-IgAN的诊断标准.
主要方法:
- 电子显微镜作为诊断的黄金标准,用于589名活检证明M-IgAN.患者的诊断.
- 计算了NS用于识别MCD-IgAN的灵敏度和特异性.
- 临床病理学数据和结果在184个非MCD-IgAN和98个MCD-IgAN病例之间进行了比较,其中包括完整的数据和随访.
主要成果:
- 在589名患者中,电子显微镜诊断出381名非MCD-IgAN,167名MCD-IgAN,以及41名其他淋巴细胞疾病.
- 在区分MCD-IgAN与非MCD-IgAN时,NS表现出高灵敏度 (83.8%) 和特异性 (99.5%).
- 与非MCD-IgAN患者相比,MCD-IgAN患者更年轻,更有可能实现缓解,并且与非MCD-IgAN患者相比,进展率更低 (P <0.05).
结论:
- 性综合征是区分MCD-IgAN与非MCD-IgAN的客观指标.
- 非MCD-IgAN在临床病理学和治疗反应方面表现出显著的差异,与MCD-IgAN相比,预后较差.
相关概念视频
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Chronic Kidney Disease III: Interprofessional Care
26
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
26
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Chronic Kidney Disease II: Clinical Manifestations
13
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
13
Acute Kidney Injury III: Clinical Manifestations
15
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
15
Chronic Kidney Disease I: Introduction
19
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
19


